1. Practical Perspectives in the Surgical Management of Parkinson Disease: LCIG

2. Introduction

3. LCIG: Purpose and Function

4. First Placebo-Controlled Trial of LCIG

5. LCIG Trial Extension

6. LCIG Trial Extension (cont)

7. LCIG: Long-Term Trial

8. LCIG: Long-Term Trial (cont)

9. GLORIA Efficacy

10. GLORIA Safety

11. LCIG Safety Across 4 Trials

12. Procedure-Related AEs in Patients Undergoing PEG-J

13. Non-Device AEs

14. Continuity of Care

15. Conclusions

16. Practical Perspectives in the Surgical Management of Parkinson Disease: DBS

17. Introduction

18. DBS Targets

19. Bilateral STN DBS vs Medical Management: PDQ-39

20. Bilateral STN DBS vs Medical Management: UPDRS-III

21. Bilateral STN DBS vs Medical Management: AEs

22. GPi and STN DBS vs Medical Management: Efficacy

23. GPi and STN DBS vs Medical Management: Safety

24. STN vs GPi DBS: CSP 468 at 24 Months

25. STN vs GPi DBS: CSP 468 at 24 Months (cont)

26. STN vs GPi: CSP 468 at 36 Months

27. STN vs GPi DBS

28. Long-Term Outcomes

29. DBS Systems

30. DBS Monitoring

31. Conclusions

32. Abbreviations